We are live on ! Find out more
ZGNX

Zogenix, Inc.

Delisted

ZGNX was delisted on the 4th of March, 2022.

166 hedge funds and large institutions have $2.55B invested in Zogenix, Inc. in 2019 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 46 increasing their positions, 47 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more call options, than puts

Call options by funds: $78.2M | Put options by funds: $42.7M

69% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 26

26% more capital invested

Capital invested by funds: $2.02B → $2.55B (+$528M)

6% more funds holding

Funds holding: 156166 (+10)

0% more funds holding in top 10

Funds holding in top 10: 1010 (0)

2% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 47

Holders
166
Holders Change
+10
Holders Change %
+6.41%
% of All Funds
3.27%
Holding in Top 10
10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.2%
New
44
Increased
46
Reduced
47
Closed
26
Calls
$78.2M
Puts
$42.7M
Net Calls
+$35.4M
Net Calls Change
-$26.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
76
Wells Fargo
California
$1.9M -$19.7K -431 -1%
NHAS
77
Novo Holdings A/S
Denmark
$1.86M
PPA
78
Parametric Portfolio Associates
Washington
$1.7M +$280K +6,105 +23%
WCM Investment Management
79
WCM Investment Management
California
$1.63M +$1.43M +31,264 New
DAM
80
DLD Asset Management
New York
$1.56M +$1.37M +30,000 New
PAI
81
Palo Alto Investors
California
$1.54M
Legal & General Group
82
Legal & General Group
United Kingdom
$1.47M +$263K +5,734 +25%
AIG
83
American International Group
New York
$1.39M -$10.3K -225 -0.8%
BG
84
Bellevue Group
Switzerland
$1.36M +$142K +3,100 +13%
Manulife (Manufacturers Life Insurance)
85
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.33M -$36.2K -791 -3%
UBS Group
86
UBS Group
Switzerland
$1.3M +$1.06M +23,111 +1,209%
CM
87
Caption Management
Oklahoma
$1.25M +$324K +7,071 +42%
Citigroup
88
Citigroup
New York
$1.17M +$217K +4,745 +27%
CSS
89
Cubist Systematic Strategies
Connecticut
$1.17M +$693K +15,128 +209%
Voloridge Investment Management
90
Voloridge Investment Management
Florida
$1.15M +$1.01M +22,117 New
State Board of Administration of Florida Retirement System
91
State Board of Administration of Florida Retirement System
Florida
$1.11M -$31.1K -680 -3%
AC
92
Athanor Capital
New York
$1.08M -$91.6K -2,001 -9%
VOYA Investment Management
93
VOYA Investment Management
Georgia
$1.08M +$165K +3,600 +21%
MIM
94
MetLife Investment Management
New Jersey
$1.01M
LCM
95
Laurion Capital Management
New York
$907K -$2.05M -44,880 -72%
Simplex Trading
96
Simplex Trading
Illinois
$895K -$1.16M -25,278 -60%
Creative Planning
97
Creative Planning
Kansas
$877K -$549 -12 -0.1%
AAM
98
Aureus Asset Management
Massachusetts
$847K
ProShare Advisors
99
ProShare Advisors
Maryland
$801K -$46.3K -1,011 -6%
WMSA
100
Weiss Multi-Strategy Advisers
New York
$782K +$687K +15,000 New

ZGNX Hedge Fund Activity: Q4 2019 in Review

166 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Zogenix, Inc. (ZGNX) for Q4 2019, worth a combined $2.55B — up 26% from $2.02B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new ZGNX positions and 26 closed out — a net gain of 18 holders — while 46 added to existing stakes and 47 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $37M. The largest seller was Great Point Partners, cutting an estimated $72.3M.

  • 166 institutional investors held Zogenix, Inc. (ZGNX) as of Q4 2019, up from 156 in Q3 2019.
  • Funds reported $2.55B of Zogenix, Inc. stock for Q4 2019, up 26% quarter-over-quarter.
  • 44 funds opened new Zogenix, Inc. positions in Q4 2019 and 26 closed out, a net change of +18 holders.
  • The largest Zogenix, Inc. buyer in Q4 2019 was T. Rowe Price Associates, an estimated $37M added.
  • The largest Zogenix, Inc. seller in Q4 2019 was Great Point Partners, an estimated $72.3M sold.

Based on aggregated 13F filings for Q4 2019.